What I need to know and what I need to do if I do not have a cytopathologist present for the procedure

Gastrointestinal Endoscopy

Volumn 69, Issue 2 SUPPL., 2009, Pages

  Ginès, Angels ^a   Solé, Manel ^a   Fernández Esparrach, Glòria ^a  

^a ICMDM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; CYTOPATHOLOGY; DIAGNOSTIC PROCEDURE; ENDOSCOPIC ECHOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HUMAN; MORPHOLOGY; PRIORITY JOURNAL; REVIEW; SMEAR;

BIOPSY; BIOPSY, FINE-NEEDLE; ENDOSONOGRAPHY; HUMANS;

EID: 58849100072     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.12.042     Document Type: Review

References (15)

1. Klapman J.B., Logroño R., Dye C., et al. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 98 (2003) 1289-1294
2. Chang K.J. Maximizing the yield of EUS-guided fine-needle aspiration. Gastrointest Endosc 56 Suppl (2002) 28-34
3. Pellisé M., Castells A., Ginès A., et al. Clinical usefulness of KRAS mutational analysis in the diagnosis of pancreatic adenocarcinoma by means of endosonography-guided fine-needle aspiration biopsy. Alimnet Pharmacol Ther 17 (2003) 1299-1307
4. Nasuti J.F., Gupta P.K., and Baloch Z.W. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol 27 (2002) 1-4
5. Ribeiro A., Vazquez-Sequeiros E., Wiersema L.M., et al. EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma. Gastrointest Endosc 53 (2001) 485-491
6. Wallace M.B., Block M.I., Gillanders W., et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 127 (2005) 418-420
7. Jhala N.C., Jhala D., Eltoum I., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a powerful tool to obtain samples from small lesions. Cancer Cytopathol 102 (2004) 239-246
8. Frossard J.L., Amouyal P., Amouyal G., et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 98 (2003) 1516-1524
9. Maksem J.A., and Weidmann J. Specialized preparative devices are not needed for liquid-based, thin-layer cytology: an alternate manual method using a metastable alcoholic gel. Diagn Cytopathol 25 (2001) 262-264
10. O'Toole D., Palazzo L., Hammel P., et al. Macrocystic pancreatic cystadenoma: the role of EUS and cystic fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc 59 (2004) 823-829
11. Brugge W.R. Should all pancreatic cystic lesions be resected? Cyst-fluid analysis in the differential diagnosis of pancreatic cystic lesions: a meta-analysis. Gastrointest Endosc 62 (2005) 390-391
12. Savoy A.D., Raimondo M., Woosward T.A., et al. Can endosonographers evaluate on-site cytologic adequacy? A comparison with cytotechnologists. Gastrointest Endosc 65 (2007) 953-957
13. LeBlanc J.K., Ciaccia D., Al-Assi M.T., et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 59 (2004) 475-481
14. Wallace M.B., Kennedy T., Durkalski V., et al. Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc 54 (2001) 441-447
15. Erickson R.A., Sayage-Rabie L., and Beissner S. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 51 (2000) 184-190